| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |